Published in Cancer Weekly, September 23rd, 2003
According to published research from South Korea, "We analyzed surface antigens, multidrug resistance (MDR) parameters (PGP, MRP, LRP), tissue infiltration parameters (CD 18, CD44, VCAM, MMP2), receptors for colony stimulating factors (G-CSFr, GM-CSFr) and cell cycle parameters (Ki-67, topoisomerase IIalpha) in 86 patients with acute lymphoblastic leukemia (ALL).
"LRP, PGP and CD 18 were associated with poor clinical outcome, and LRP expression was related with CDI 8, CD44 and G-CSFr," wrote E.J. Oh and colleagues, Catholic University...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.